Mexico's antitrust watchdog say more generic drug competition needed

Mexico's antitrust watchdog say more generic drug competition needed

Mexico's antitrust watchdog says the country needs to remove regulatory barriers to generic drug competition.

Unlock unlimited access to all Latin Lawyer content